Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-15-031824)

Filing Details

Accession Number:: 0001140361-15-031824
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-14 09:29:46
Reporting Period:: 2015-08-13

Filing Date:: 2015-08-14
Accepted Time:: 2015-08-14 09:29:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367644	Emergent Biosolutions Inc.	EBS	Pharmaceutical Preparations (2834)	141902018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1222197	A George Joulwan	400 Professional Dr, Suite 400 Gaithersburg MD 20879		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-08-13	7,200	$17.51	26,700	No	4	M	Direct
Common Stock	Disposition	2015-08-13	7,200	$34.72	19,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock	Disposition	2015-08-13	7,200	$0.00	7,200	$17.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,600		2020-07-16	No	4	M	Direct

Footnotes

Consists of an option granted under the company's stock incentive plan on July 17, 2013.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.71 to $34.81, inclusive.
The option vests in three equal installments in July 2014, 2015 and 2016.